CDC40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.72895031624876E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.74099995215494E-09 |
Normal-vs-Stage2 |
4.583100E-04 |
Normal-vs-Stage3 |
6.83897383169096E-14 |
Normal-vs-Stage4 |
1.88737914186277E-14 |
Stage1-vs-Stage2 |
5.720000E-01 |
Stage1-vs-Stage3 |
2.323500E-03 |
Stage1-vs-Stage4 |
4.018100E-04 |
Stage2-vs-Stage3 |
2.584200E-01 |
Stage2-vs-Stage4 |
1.034240E-01 |
Stage3-vs-Stage4 |
4.056000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.99384952992432E-12 |
Normal-vs-AfricanAmerican |
5.49599998844741E-09 |
Normal-vs-Asian |
2.481800E-02 |
Caucasian-vs-AfricanAmerican |
3.290400E-01 |
Caucasian-vs-Asian |
6.802800E-01 |
AfricanAmerican-vs-Asian |
3.809800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.11652958784725E-14 |
Normal-vs-Female |
5.97149996117707E-10 |
Male-vs-Female |
2.617600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.18419999999231E-05 |
Normal-vs-Age(41-60Yrs) |
1.14660003713851E-09 |
Normal-vs-Age(61-80Yrs) |
1.46105350040671E-13 |
Normal-vs-Age(81-100Yrs) |
7.98679999913787E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.554400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.260800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.366000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.308200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.909950E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.990000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.101400E-01 |
Normal-vs-Grade 2 |
9.30080000016709E-07 |
Normal-vs-Grade 3 |
5.6621374255883E-15 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
2.708300E-02 |
Grade 1-vs-Grade 3 |
2.896100E-03 |
Grade 1-vs-Grade 4 |
1.78019999996781E-06 |
Grade 2-vs-Grade 3 |
6.634900E-04 |
Grade 2-vs-Grade 4 |
5.82180004204957E-09 |
Grade 3-vs-Grade 4 |
1.702490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.281520E-03 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
3.66840002818947E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.08050013380989E-10 |
Normal-vs-N1 |
2.787300E-04 |
N0-vs-N1 |
7.641500E-02 |
|
|